Huron Consulting Group Inc. Q2 2026 Earnings Call Summary
Strategic Performance Drivers Achieved record RBR growth of 16% driven by strong organic performance across all three segments and a meaningful step-up in digital capabilities. Healthcare segment growth of 17% was fueled by persistent financial challenges for providers, including rising labor and supply costs that outpace reimbursements.
How this was made
The 30-second read
Why it matters
Traders can update 2026 revenue and leverage expectations using the raised RBR range, the free-cash-flow projection ($180M-$220M), and the leverage target (2.0x-2.5x). The RelateCare acquisition adds a quantified RBR contribution for 2026, while commercial segment annualization and project wind-down introduce a second-half growth headwind.
Market read
The call provides concrete 2026 guidance ranges and quantified growth drivers (including AI scope in digital bookings and RelateCare’s RBR contribution), which can drive model revisions and near-term positioning.
What to watch
Utilization is above the preferred steady-state (77%-79%), so capacity constraints and hiring ramp could affect delivery margins even if AI reduces assessment cycle times.
Background
This is a Q2 2026 earnings call summary for Huron, emphasizing AI-enabled digital bookings, managed services growth, and updated 2026 guidance plus capital allocation.
Ticker impact
Huron raised full-year RBR guidance to $1.85B-$1.89B and guided leverage to 2.0x-2.5x by year-end 2026.
Likely positive near-term bias as traders reprice 2026 RBR and margin trajectory, tempered by second-half commercial headwinds.
The article provides specific updated guidance ranges, a leverage target, and quantified growth drivers (including RelateCare contribution), which are actionable for earnings-model updates.
Market effects
Consulting and healthcare IT services peers may see read-across demand for AI-enabled revenue cycle and managed services, especially if healthcare provider cost pressures persist.
No clear regional-specific impact beyond US healthcare policy tailwinds referenced in the call.
Limited direct global linkage; AI modernization and managed-services demand are broadly relevant but the disclosed assumptions are US healthcare policy focused.
Counterpoint
The guidance increase may rely on optimistic assumptions about healthcare regulatory tailwinds and sustained AI backlog conversion, while commercial advisory project wind-down could pressure near-term execution.
Key entities
- public_companyHuron Consulting Group Inc.
Raised full-year RBR guidance to $1.85B-$1.89B, guided leverage to 2.0x-2.5x by year-end 2026, and highlighted AI-driven digital bookings and managed services growth.
- acquired_companyRelateCare
Acquired in Q2 to expand AI-enabled clinical and patient access managed services, expected to contribute $30M in RBR for 2026.
- legislationOBBBA legislation
Projected to reduce federal healthcare spending by over $1T over 10 years, cited as a long-term demand tailwind for Huron’s performance improvement services.
